| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |